Safrole induces apoptosis in human oral cancer HSC-3 cells

J Dent Res. 2011 Feb;90(2):168-74. doi: 10.1177/0022034510384619. Epub 2010 Dec 20.

Abstract

Phytochemicals have been used as potential chemopreventive or chemotherapeutic agents. However, there are data suggesting a mutagenic effect of some phytochemicals. We hypothesized that safrole would have anticancer effects on human oral squamous cell carcinoma HSC-3 cells. Safrole decreased the percentage of viable HSC-3 cells via induction of apoptosis by an increased level of cytosolic Ca(2+) and a reduction in the mitochondrial membrane potential (ΔΨ(m)). Changes in the membrane potential were associated with changes in the Bax, release of cytochrome c from mitochondria, and activation of downstream caspases-9 and -3, resulting in apoptotic cell death. In vivo studies also showed that safrole reduced the size and volume of an HSC-3 solid tumor on a xenograft athymic nu/nu mouse model. Western blotting and flow cytometric analysis studies confirmed that safrole-mediated apoptotic cell death of HSC-3 cells is regulated by cytosolic Ca(2+) and by mitochondria- and Fas-dependent pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Apoptosis*
  • Calcium / metabolism
  • Carcinoma, Squamous Cell / drug therapy*
  • Caspase 3 / metabolism
  • Caspase 8 / metabolism
  • Caspase 9 / metabolism
  • Cell Line, Tumor / drug effects
  • Cytochromes c / metabolism
  • DNA Damage
  • Fas Ligand Protein / metabolism
  • Humans
  • Male
  • Membrane Potential, Mitochondrial / drug effects*
  • Mice
  • Mice, Nude
  • Mouth Neoplasms / drug therapy*
  • Neoplasm Transplantation
  • Safrole / pharmacology*
  • Safrole / therapeutic use
  • Statistics, Nonparametric

Substances

  • Fas Ligand Protein
  • Cytochromes c
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Safrole
  • Calcium